Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03646045 · ClinicalTrials.gov registry record

Transpyloric Feeding for Prevention of Micro-aspiration

A clinical trial of Gastroesophageal Reflux and Microaspiration, sponsored by Nemours Children's Clinic.

Active
Registry status
46
Enrollment target
2
Study locations

NCT03646045: Active study of Gastroesophageal Reflux and Microaspiration, sponsored by Nemours Children's Clinic.

NCT03646045 is a study of Gastroesophageal Reflux and Microaspiration that is active but no longer recruiting, run by Nemours Children's Clinic. The registered enrollment target is 46 participants, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03646045, a study of Gastroesophageal Reflux and Microaspiration, is active but no longer recruiting, sponsored by Nemours Children's Clinic.

ACTIVE NOT RECRUITING
Registry status
46 participants
Enrollment target
2
Study locations

Study Summary

To determine the effect of transpyloric (TP) feeding on microaspiration and lung inflammation in ventilated preterm infants.

Primary Outcome

Difference in tracheal aspirate pepsin A levels in preterm ventilated infants receiving transpyloric feeding and gastric feeding.

Interventions

  • OTHER Transpyloric feeding

Study Locations (2)

Delaware

  • AI duPont Hospital for Children - Wilmington

Pennsylvania

  • Thomas Jefferson University Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2016-11-04
Est. Completion 2026-12-15
Nemours Children's Clinic

108 total trials

What the registry record for NCT03646045 still lists

NCT03646045 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 2,885-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Transpyloric feeding is the first listed.

NCT03646045 reports a single indexed study location in Delaware, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03646045 about?

NCT03646045 is a clinical study titled "Transpyloric Feeding for Prevention of Micro-aspiration". To determine the effect of transpyloric (TP) feeding on microaspiration and lung inflammation in ventilated preterm infants.

What is the current status of trial NCT03646045?

This trial is currently active not recruiting. The enrollment target is 46 participants. The study started on 2016-11-04. Estimated completion is 2026-12-15.

What conditions does trial NCT03646045 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux, Microaspiration.

What interventions are being tested in trial NCT03646045?

The interventions under investigation include: Transpyloric feeding (OTHER).

Who is sponsoring clinical trial NCT03646045?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03646045 being conducted?

This trial has 2 study locations across Delaware, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03646045's enrollment target sits among peer trials

46 23rd of 33 higher than 11 of 33 other Gastroesophageal Reflux trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03646045, the US trial registry maintained by the National Library of Medicine. NCT03646045 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.